Intuitive Surgical Inc (ISRG) operating KPIs
ISRGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 17/3023% above fair value
$432.01−16.75 (-3.73%)
Close on Oct 30, 2026Market cap $152.62BP/E 49.5Yield –
Intuitive Surgical ion Endoluminal Lung Biopsy Procedures Performed
Form 10-Q / 10-K MD&A ('Ion Procedures')
Latest, Q3 2026
49,700
Period ended Sep 30, 2026
Change on a year earlier
+31.1%
37,900 in Q3 2025
History
7 quarters
Since Q1 2025
Sources
4
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Ion Endoluminal Lung Biopsy Procedures Performed | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 49,700 | +31.1% | SEC Filing (0001035267-26-000071) ↗ |
| Q2 2026 | Jun 30, 2026 | 47,900 | +35.7% | SEC Filing (0001035267-26-000058) ↗ |
| Q1 2026 | Mar 31, 2026 | 42,700 | +39.1% | SEC Filing (0001035267-26-000032) ↗ |
| Q4 2025 | Dec 31, 2025 | 40,200 | – | SEC Filing (0001035267-26-000010) ↗ |
| Q3 2025 | Sep 30, 2025 | 37,900 | – | SEC Filing (0001035267-26-000071) ↗ |
| Q2 2025 | Jun 30, 2025 | 35,300 | – | SEC Filing (0001035267-26-000058) ↗ |
| Q1 2025 | Mar 31, 2025 | 30,700 | – | SEC Filing (0001035267-26-000032) ↗ |
Breakdown
What makes up ion endoluminal lung biopsy procedures performed
Cite this data
StockData. (2026). Intuitive Surgical Ion Endoluminal Lung Biopsy Procedures Performed, quarterly Q1 2025–Q3 2026 [Data set]. Compiled from Intuitive Surgical SEC filings and investor materials. https://stockdatahq.com/stocks/isrg/kpis/ion-proc-total
See every metric in the Intuitive Surgical KPI table. Data updated Oct 28, 2026.